Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | NOS1 | P29475 | 4/20 | 0.48 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.47 |
| ▸ | MIF | P14174 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | NOS3 | P29474 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitroscanate SCHEMBL381451 | 0.91 | HSPB1 (0.56) | PLAUCA1CA2ALDH1A1HSD17B10 | |
| Amoscanate SCHEMBL159478 | 0.89 | HPGD (0.56) | PLAUCA1CA2NOS1ALDH1A1 | |
| SCHEMBL10622842 | 0.89 | MAPT (0.54) | PLAUCA1CA2NOS1P2RY6 | |
| SCHEMBL6894771 | 0.85 | ALDH1A1 (0.50) | MIFALDH1A1LMNASMN1; SMN2MAPT | |
| Nitrobenzene SCHEMBL27619235 | 0.83 | ALDH1A1 (0.52) | PLAUCA1CA2NOS1P2RY6 | |
| SCHEMBL508121 | 0.83 | PLAU (0.53) | PLAUCA1CA2NOS1ALDH1A1 | |
| SCHEMBL11720520 | 0.82 | MEN1 (0.40) | PLAUCA1CA2NOS1ALDH1A1 | |
| SCHEMBL62027 | 0.81 | PLAU (0.52) | PLAUCA1CA2NOS1ALDH1A1 | |
| SCHEMBL11710183 | 0.79 | NPC1 (0.40) | CA1CA2ALDH1A1APPLMNA | |
| SCHEMBL15630319 | 0.79 | P2RY6 (0.47) | PLAUCA1CA2NOS1P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 609 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12402638-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2025-09-02 | — | — | US | claimed |
| CN-115515998-B | Synthesis of polyurethanes by chain growth copolymerization | 伊夫·雅努 | 2025-06-24 | — | — | CN | claimed |
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| US-20250100980-A1 | NOVEL LEUKOTRIENE B4 RECEPTOR INHIBITORS AND USE THEREOF | EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION (KR) | 2025-03-27 | — | — | US | claimed |
| US-12232516-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2025-02-25 | — | — | US | claimed |
| US-12193465-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2025-01-14 | — | — | US | claimed |
| CN-119080660-A | Thiosemicarbazide menthyl formate compound, preparation method and application thereof | 南京林业大学 | 2024-12-06 | — | — | CN | claimed |
| CN-115894909-B | Polyethylenimine nitrophenyl thiourea probe, preparation method and application thereof in recognition of anions | 新疆大学 | 2024-06-04 | — | — | CN | claimed |
| US-20230380457-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-30 | — | — | US | claimed |
| WO-2010065329-A2 | NANOPARTICLES FOR CANCER TREATMENT | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-06-10 | — | — | WO | claimed |
| US-7732534-B2 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2010-06-08 | — | — | US | claimed |
| WO-2009066981-A1 | IMMOBILIZED NITRATE IONOPHORE | MIMOS BERHAD (MY) | 2009-05-28 | — | — | WO | claimed |
| US-20080051552-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION | 2008-02-28 | — | — | US | claimed |
| US-20080051519-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2008-02-28 | — | — | US | claimed |
| CN-100351229-C | 5,11,17,23-tetra (p-tert-butyl)-25,27-dilp-nitrobenzenethioureido-(1'R,2'R)-1',2'-diphenylethylamino-carbonyl methoxyl J-26, 28-dihydroxyl cup [4} arene | UNIV WUHAN (CN) | 2007-11-28 | — | — | CN | claimed |
| US-20060241178-A1 | Compositions and methods for treating lung cancer | IMMUNEGUARD LLC (US) | 2006-10-26 | — | — | US | claimed |
| CN-1810784-A | 5,11,17,23-tetra (p-tert-butyl)-25,27-dilp-nitrobenzenethioureido-(1'R,2'R)-1',2'-diphenylethylamino-carbonyl methoxyl J-26, 28-dihydroxyl cup [4} arene | UNIV WUHAN (CN) | 2006-08-02 | — | — | CN | claimed |
| WO-2004060365-A1 | COMPOSITIONS AND METHODS FOR TREATING LUNG CANCER | AMERICAN HEALTH FOUNDATION (US) | 2004-07-22 | — | — | WO | claimed |
| EP-0928311-B1 | SHAPING OBJECT WITH REACTIVE FUNCTIONS | BIOTECHNOLOG FORSCHUNG GMBH (DE) | 2003-04-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250100980-A1 | NOVEL LEUKOTRIENE B4 RECEPTOR INHIBITORS AND USE THEREOF | LTB4R2, LTB4R, CYSLTR2 | PLAU 473/4885CA1 4790/4885CA2 4126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.